72734-74-8Relevant academic research and scientific papers
Preparation method of 2-(4-benzyloxyphenyl)ethanol
-
Paragraph 0063; 0071-0073; 0084; 0085; 0094; 0095, (2021/08/06)
The invention provides a preparation method of 2-(4-benzyloxyphenyl)ethanol. The preparation method comprises the following steps: 1) subjecting phenol to reacting with chloroacetyl chloride under the catalysis of aluminum trichloride to obtain a compound as shown in a formula II; 2) subjecting the compound as shown in the formula II to reacting with benzyl halide under an alkaline condition to obtain a compound as shown in a formula III, wherein the benzyl halide is one selected from benzyl bromide and benzyl chloride; 3) performing reduction treatment on the compound as shown in the formula III, and adjusting a reaction system to be an alkaline system to obtain a compound as shown in a formula IV; and 4) under the action of a catalyst, reducing the compound as shown in the formula IV under a hydrogen condition to obtain the 2-(4-benzyloxyphenyl)ethanol as shown in the formula I. The preparation method has the advantages of low cost, mild reaction conditions, safety in operation and less three-waste pollution, and is beneficial to being applied to industrial production.
A mild catalytic oxidation system: Ruthenium porphyrin and 2,6-dichloropyridine n-oxide applied for alkene dihydroxylation
Hu, Wen-Xiang,Li, Pei-Rong,Jiang, Gaoxi,Che, Chi-Ming,Chen, Jian
scheme or table, p. 3190 - 3194 (2011/02/23)
A new method was developed to transform alkenes into three types of functional molecules, including epoxides, aldehydes and 1,2-diols by using dichlororuthenium(IV) meso-tetrakis(2,6-dichlorophenyl)porphyrin [Ru(IV)(TDCPP)Cl2] as catalyst and 2,6-dichloropyridine N-oxide (Cl2pyNO) as the oxidant, in which the 1,2-diols were afforded via "one-pot" reactions in moderate yields. Copyright
CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
-
Page/Page column 33, (2008/12/07)
This invention relates to novel compounds of the Formula (I), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful for the therapeutic treatment of diseases associated with the modulation or inhibition of 11 beta-HSD1 in mammals. The invention further relates to pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.
1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
-
, (2008/06/13)
This invention relates to a 1,2-ethanediol derivative and a salt thereof, a process for producing the same, and a cerebral function improving agent comprising the same. The cerebral function-improving agent of this invention is useful for treating cerebrovascular dementia, senile dementia, Alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy.
